Joint Formulary & PAD

Azelastine hydrochloride - Allergic rhinitis

You are here : Home > Formulary Search > Azelastine hydrochloride - Allergic rhinitis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Nasal spray
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines
SPC
Restrictions / Comments :
Important

Recommended as an alternative where an intranasal antihistamine is indicated

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Azelastine hydrochloride
Indication :
Allergic rhinitis
Group Name :
Keywords :
Hay fever, hayfever, antihistamines, nasal sprays, allergy, seasonal allergic rhinitis, intranasal antihistamines, pollen allergy, non-sedating antihistamines
Brand Names Include :
Rhinolast, Aller-eze, Azelair
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Allergic rhinitis
Supporting Documents :
0

Committee Recommendations (1)

05 Apr 23 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

Azelastine is the only intranasal antihistamine that is licensed in the UK for the treatment of allergic rhinitis.
It was agreed as a treatment option for intermittent mild symptoms where it has a fast onset of action.
See local guidelines below

Other Indications

Below are listed other indications that Azelastine hydrochloride is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Allergic rhinitis.